News

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Weight loss jabs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro) have surged in popularity, becoming one ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Weight loss drugs can cause side effects including nausea, vomiting, diarrhoea, haemorrhoids and constipation, which can ...
Clinical trials have shown that Wegovy can lead to an average weight loss of 15-18% over 68 weeks. It is approved for use in individuals with a BMI of 30 or greater or those with a BMI of 27 or ...
Ozempic, widely used for weight loss, is now linked to a surprising side effect—'Ozempic feet'—marked by foot fat loss, ...
Scientifically Designed 4-Stage Fat Loss Supplement Offers Safe, Non-Prescription Alternative to GLP-1 Drugs Like ...
BLOCKBUSTER ‘Ozempic-style’ fat jabs could increase the risk of depression and suicidal thoughts, experts have warned. The ...
Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...